Neurotrophins sales will grow through 2036, led by nerve growth factor at 36.0% of the product segment in 2026. The market was valued at USD 6.20 billion in 2025 and is expected to reach USD 13.05 billion by 2036, creating an incremental opportunity of USD 6.42 billion between 2026 and 2036.